Corpus ID: 377592

Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.

@article{Lee2006InhibitionON,
  title={Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid.},
  author={J. Lee and T. H. Koo and Hyunkyung Yoon and H. Jung and H. Z. Jin and K. Lee and Young-Soo Hong},
  journal={Biochemical pharmacology},
  year={2006},
  volume={72 10},
  pages={
          1311-21
        }
}
  • J. Lee, T. H. Koo, +5 authors J. Lee
  • Published 2006
  • Medicine
  • Biochemical pharmacology
  • Celastrol, a quinone methide triterpenoid, was isolated as an inhibitor of NF-kappaB from Celastrus orbiculatus. This compound dose-dependently inhibited a variety of stimuli-induced NF-kappa B-regulated gene expression and the DNA-binding of NF-kappa B in different cell lines without affecting DNA-binding activity of AP-1. Preincubation of celastrol completely blocked the LPS-, TNF-alpha-, or PMA-induced degradation and phosphorylation of I kappa B alpha. Importantly, celastrol inhibited IKK… CONTINUE READING
    109 Citations
    Amorfrutin A inhibits TNF-α-induced NF-κB activation and NF-κB-regulated target gene products.
    • 19
    The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma
    • 61